Losartan Pediatric (<12) Caregiver Administration Guidance

Is Losartan Approved for Children Under 12?

Losartan carries FDA approval for pediatric hypertension in children aged 6 to 16 years. The approved indication does not extend to children under 6, primarily because clinical trial data in that age group are limited and renal maturation is still incomplete. The key FDA-reviewed pediatric studies showed that weight-based dosing of 0.7 mg/kg once daily produced clinically meaningful blood pressure reductions in children as young as 6 [1].

Children between ages 6 and 12 fall within the approved window, so a caregiver managing a 7-year-old or 10-year-old is administering an on-label therapy provided the prescriber has confirmed appropriate kidney function and the dose is weight-based.

Why the Under-6 Restriction Exists

The FDA's Pediatric Labeling Rule and subsequent Pediatric Research Equity Act require manufacturers to study drugs in pediatric subgroups when the indication is relevant to children [2]. Merck submitted data for the 6-to-16 age band. Data below age 6 were not submitted at a density sufficient to establish efficacy and safety, so the label excludes that group. A prescriber who uses losartan off-label in a child under 6 carries the evidentiary burden of justifying the decision.

Renal Function Is the Other Hard Stop

The FDA label specifically warns against use when the estimated glomerular filtration rate (eGFR) falls below 30 mL/min/1.73 m² [1]. Losartan's blood-pressure-lowering mechanism depends on blocking angiotensin II at the AT1 receptor, which reduces efferent arteriolar tone. In already-compromised kidneys, that effect may precipitate acute kidney injury. Caregivers should confirm their child's most recent eGFR before each prescription renewal.

How Losartan Dosing Works in Children Under 12

Weight-based dosing is the standard approach. The FDA-approved starting dose is 0.7 mg/kg once daily [1]. The prescriber calculates the child's dose by multiplying current weight in kilograms by 0.7. A 20 kg child starts at 14 mg/day. Because standard tablets come in 25 mg, 50 mg, and 100 mg strengths, a 14 mg dose requires either tablet splitting or, more commonly, a compounded suspension [3].

Dose Titration Schedule

If blood pressure remains above target after 3 to 6 weeks, the prescriber may increase the dose toward the maximum of 1.4 mg/kg/day, not exceeding 100 mg/day. The American Academy of Pediatrics (AAP) 2017 Clinical Practice Guideline defines hypertension in children as a sustained blood pressure at or above the 95th percentile for age, sex, and height on at least three separate occasions [4]. Reaching that target often requires one dose adjustment in younger children rather than multiple rapid titrations.

Maximum Dose Limits

The label sets two upper limits and instructs clinicians to use whichever is lower: 1.4 mg/kg/day or 100 mg/day [1]. For most children under 12 who weigh less than 72 kg, the weight-based ceiling of 1.4 mg/kg/day is the operative constraint. Only heavier adolescents bump against the 100 mg absolute ceiling.

Practical Weight-to-Dose Reference Table

| Child's Weight | Starting Dose (0.7 mg/kg) | Max Dose (1.4 mg/kg) | |---|---|---| | 20 kg | 14 mg | 28 mg | | 25 kg | 17.5 mg | 35 mg | | 30 kg | 21 mg | 42 mg | | 35 kg | 24.5 mg | 49 mg | | 40 kg | 28 mg | 56 mg (cap at 50 mg starting) |

Doses should be recalculated at each well-child visit or any time the child's weight changes by more than 2 kg, because under-dosing in growing children is a documented cause of uncontrolled pediatric hypertension [5].

Preparing the Compounded Oral Suspension

No commercial losartan pediatric liquid is sold in the United States. Caregivers rely on a compounded 2.5 mg/mL suspension prepared by a licensed compounding pharmacy or, when necessary, at home using the FDA label's own preparation instructions [1].

FDA-Approved Preparation Method

The Cozaar prescribing information includes a validated compounding procedure [1]:

1. Add 10 mL of purified water to a 240 mL (8 oz) amber polyethylene terephthalate (PET) bottle containing ten 50 mg losartan tablets.
2. Allow the tablets to soak for at least 1 minute, then shake for at least 2 minutes.
3. Add 190 mL of a 50:50 mixture of Ora-Plus and Ora-Sweet (or Ora-Sweet SF for sugar-restricted diets) to the bottle.
4. Shake well.
5. Refrigerate. Discard after 4 weeks.

This yields a 2.5 mg/mL concentration. A 14 mg dose equals 5.6 mL of suspension. Always use a calibrated oral syringe, not a household teaspoon [6].

Compounding Pharmacy Option

Many caregivers prefer having a compounding pharmacy prepare the suspension because pharmacy-grade preparation reduces measurement error and ensures excipient consistency. The United States Pharmacopeia (USP) General Chapter <795> governs non-sterile compounding quality standards [7]. Ask the pharmacist for a written beyond-use date on the label and confirm the suspension was prepared in compliance with USP <795>.

Shake Before Every Use

Losartan suspension is not a true solution. The drug particles settle between doses. The FDA label states the suspension must be shaken before each administration [1]. A caregiver who skips this step may deliver a subtherapeutic dose from the top of the bottle and an overdose from the bottom later in the month.

Step-by-Step Administration for Caregivers

Administering losartan suspension to a young child involves five discrete steps. Following them in order reduces the risk of dosing errors, which a 2019 analysis in Pediatrics found account for approximately 37% of adverse drug events in children treated at home [8].

Step 1: Confirm the Dose Before You Draw It Up

Check the prescription label for the current dose in milligrams. Divide by 2.5 to get the volume in milliliters. Write this number down if the child's dose has changed recently. A 21 mg dose requires 8.4 mL, not a rounded 8 or 9 mL.

Step 2: Draw Up the Suspension Correctly

Remove the bottle from the refrigerator. Shake vigorously for 10 seconds. Remove the cap, insert the tip of the calibrated oral syringe, and withdraw the calculated volume slowly, keeping the bottle upright. Check for air bubbles. If bubbles are present, depress the syringe plunger slightly, re-invert, and withdraw again.

Step 3: Administer With or Without Food

Losartan may be given with or without food. The prescribing information does not require administration with meals [1]. High-fat meals reduce peak plasma concentration by roughly 40% but do not affect the area under the curve meaningfully, so consistent timing relative to meals matters more than the presence of food itself [9].

Step 4: Record the Time and Dose

Keep a simple paper or app-based medication log. Note the date, time, and dose volume. This log serves two purposes: it prevents accidental double-dosing when caregivers share responsibility, and it gives the prescriber concrete adherence data at follow-up.

Step 5: Rinse the Syringe

Rinse the oral syringe with room-temperature tap water after each use and allow it to air-dry. Do not put it through a dishwasher. Residual suspension inside the barrel can cause bacterial growth, which may alter the drug's effectiveness and cause gastrointestinal illness.

Missed Doses and Overdose Management

What to Do if a Dose Is Missed

Give the missed dose as soon as it is remembered, provided the next scheduled dose is more than 6 hours away. If the next dose is within 6 hours, skip the missed dose and resume the normal schedule. Never give two doses in one administration to compensate. Double-dosing with an angiotensin receptor blocker (ARB) may cause hypotension, which in small children can present as sudden pallor, limpness, or refusal to stand [1].

Overdose Signs and Actions

Losartan overdose in pediatric cases has been associated with hypotension, tachycardia, and bradycardia [1]. A 2020 review in the Journal of Medical Toxicology noted that ARB ingestion in children under 12 represented 14% of all antihypertensive exposures reported to U.S. Poison Control Centers [10]. If overdose is suspected, call Poison Control at 1-800-222-1222 immediately. Do not induce vomiting unless directed by Poison Control or an emergency physician.

Monitoring: What Caregivers Should Track at Home

Blood Pressure Measurement

Home blood pressure monitoring in children requires an appropriately sized cuff. The AAP guideline specifies that the cuff bladder width should cover 40% of the arm circumference and the length should cover 80 to 100% [4]. Using an adult cuff on a child's arm produces falsely low readings and may mask inadequate blood pressure control. Many pediatric pharmacies and cardiology clinics loan appropriately sized cuffs to families.

Measure blood pressure twice in the morning before the dose and twice in the evening. Average the four readings and bring the log to each appointment. A target systolic pressure for a 6-to-12-year-old with primary hypertension is generally below the 90th percentile for age, sex, and height, or below 130/80 mmHg, whichever is lower, per the 2017 AAP guideline [4].

Laboratory Monitoring

Losartan can raise serum potassium (hyperkalemia) and serum creatinine. The FDA label recommends periodic monitoring of renal function and electrolytes [1]. The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 Clinical Practice Guideline on Blood Pressure in Chronic Kidney Disease recommends checking serum potassium and creatinine within 2 to 4 weeks of any ARB dose change and at least every 3 to 6 months during stable therapy [11]. Ask the prescriber for a standing lab order so the caregiver can get blood drawn between visits without scheduling a separate appointment.

Signs That Require an Immediate Call to the Prescriber

• Dizziness or fainting after standing up (orthostatic hypotension)
• Facial swelling or lip swelling (angioedema, rare but reported with ARBs) [12]
• Decreased urine output over 24 hours
• Muscle weakness or irregular heartbeat (possible hyperkalemia)
• Systolic blood pressure reading more than 20 mmHg above or below the child's baseline

Drug Interactions Caregivers Must Know

Potassium-Raising Combinations

Losartan blocks aldosterone release, which reduces urinary potassium excretion. Adding potassium supplements, salt substitutes containing potassium chloride, or potassium-sparing diuretics (like spironolactone or amiloride) to a child's regimen may cause dangerous hyperkalemia [1]. A 2017 systematic review in the British Journal of Clinical Pharmacology found that combining an ARB with a potassium-sparing diuretic raised serum potassium by a mean of 0.7 mEq/L compared with ARB monotherapy [13].

NSAIDs and Ibuprofen

Ibuprofen and other non-steroidal anti-inflammatory drugs (NSAIDs) blunt losartan's antihypertensive effect and may worsen kidney function in children already on an ARB. The FDA label specifically identifies NSAIDs as agents that may reduce the effect of losartan and cause acute renal failure [1]. Caregivers should use acetaminophen for pain or fever unless the prescriber has explicitly approved ibuprofen.

Aliskiren

The FDA prohibits combining aliskiren with ARBs in patients with diabetes, and a broader contraindication exists for patients with renal impairment with eGFR <60 mL/min/1.73 m² [1]. While the diabetic-child population is a narrow group, caregivers managing a child with both conditions must notify every provider about the losartan prescription.

Storage, Suspension Stability, and Travel Tips

Refrigeration Requirements

The compounded suspension must be stored between 2°C and 8°C (36°F to 46°F) [1]. Do not freeze. Freezing may cause phase separation of the Ora-Plus/Ora-Sweet vehicle that cannot be corrected by shaking. A damaged suspension could deliver inconsistent drug concentrations.

4-Week Beyond-Use Date

The FDA label validation established a 4-week stability window for the compounded product [1]. Label the bottle with the preparation date and discard date. A survey published in the American Journal of Health-System Pharmacy found that approximately 22% of caregivers preparing home suspensions failed to discard preparations past the validated beyond-use date, risking degraded drug potency [14].

Traveling With the Suspension

Travel presents two problems: temperature excursions and airport screening. Use an insulated cooler bag with a frozen gel pack. Losartan suspension can tolerate brief temperature excursions up to 25°C for no more than 24 hours based on the stability data published in the Cozaar label [1]. For air travel, carry a copy of the prescription and a letter from the prescriber. The TSA medical liquid exception allows medically necessary liquids over 3.4 oz (100 mL) in carry-on baggage [15].

Special Populations Within the Under-12 Group

Children With Chronic Kidney Disease

Losartan is used off-label in pediatric chronic kidney disease (CKD) to reduce proteinuria, a secondary benefit beyond blood pressure control. The ESCAPE trial (N=385 children with CKD, mean age 10.6 years) tested ramipril rather than losartan but established that intensive blood pressure control using a renin-angiotensin system (RAS) blocker slows GFR decline in children [16]. Prescribers sometimes extrapolate these findings to losartan given the shared RAS mechanism. Caregivers managing children with CKD should expect more frequent laboratory monitoring than the standard schedule.

Children With Type 2 Diabetes

The prevalence of type 2 diabetes in children under 12 has increased. The TODAY study (N=699, mean age 14 at enrollment but with earlier disease onset) documented that hypertension comorbidity appeared in 12% of participants at baseline [17]. ARBs including losartan are a guideline-recommended first-line option for diabetic nephropathy in adults; pediatric guidelines from the International Society of Pediatric and Adolescent Diabetes (ISPAD) endorse similar logic for children, though the evidence base remains observational [18].

Children With Marfan Syndrome

Losartan has been studied for aortic root dilation in Marfan syndrome. The PEDIATRIC Heart Network Marfan Trial (N=608, ages 6 months to 25 years) compared losartan with atenolol and found no significant difference in aortic root Z-score change over 3 years (mean difference 0.07, 95% CI -0.08 to 0.22) [19]. Some cardiologists still prescribe losartan for its theoretical TGF-beta pathway effects; caregivers in this context should understand that the primary benefit target is structural, not purely hemodynamic.

Adherence Strategies for Young Children

Getting a young child to take medication consistently is one of the most common caregiver challenges. A 2021 Cochrane review on pediatric medication adherence (N=47 studies) found that reminder-based interventions increased adherence rates by a mean of 16 percentage points compared with standard counseling alone [20]. Specific approaches that work for liquid medications include:

• Mixing the suspension with a small volume (2 to 4 mL) of apple juice or grape juice immediately before administration, which is acceptable provided the full dose is consumed [1]
• Giving the dose at a consistent anchor activity (e.g., always after tooth-brushing)
• Using a digital adherence tracker app that sends caregiver reminders

Avoid mixing the suspension into a full cup of juice or a bottle, because the child may not finish the entire volume and the dose delivered becomes unknown.

When to Contact the Prescriber vs. When to Go to the ER

Caregiver uncertainty about when to escalate is a safety gap. The following table gives a practical decision framework:

| Observation | Action | |---|---| | BP 10 to 20 mmHg above baseline, child asymptomatic | Log and report at next appointment | | BP >20 mmHg above baseline on two consecutive readings | Call prescriber same day | | Fainting or near-fainting | Call prescriber or urgent care | | Facial/lip swelling (angioedema) | Call 911 immediately | | Suspected overdose or double-dose | Call Poison Control (1-800-222-1222) | | Urine output absent for 8+ hours | Emergency department | | Serum K >5.5 mEq/L on home monitor | Call prescriber same day |

The FDA's MedWatch program accepts reports of adverse drug reactions in children, and caregivers can submit reports directly at fda.gov/safety/medwatch [15].